Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 325001 - 325020 out of 495964 entries
Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
---|---|---|---|---|---|---|---|---|
Luxembourg | (L01EA03) nilotinib (adm: O) | Nilotinib EG GELUL. 50 mg 3*40 *1 gélules(unidoses) | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01EB09) lazertinib | Lazcluze CPR.PELLIC. 240 mg 1*28 cpr.ss blist. | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | n/a |
Luxembourg | (L01EB09) lazertinib | Lazcluze CPR.PELLIC. 80 mg 1*56 cpr.ss blist. | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | n/a |
Luxembourg | (L01EJ04) momelotinib | Omjjara CPR.PELLIC. 100 mg 1*30 cpr.(flacon PEHD) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | n/a |
Luxembourg | (L01EJ04) momelotinib | Omjjara CPR.PELLIC. 150 mg 1*30 cpr.(flacon PEHD) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | n/a |
Luxembourg | (L01EJ04) momelotinib | Omjjara CPR.PELLIC. 200 mg 1*30 cpr.(flacon PEHD) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Splenomegaly;Myeloproliferative Disorders | n/a |
Luxembourg | (L01EK01) axitinib (adm: O) | Axitinib EG CPR.PELLIC. 1 mg 56*1 cpr.U.D. | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01EK01) axitinib (adm: O) | Axitinib EG CPR.PELLIC. 5 mg 56*1 cpr.U.D. | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L01EX03) pazopanib (adm: O) | VOTRIENT CPR.PELLIC. 200 mg 1*90 CPR.(FL.) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | n/a |
Luxembourg | (L01EX03) pazopanib (adm: O) | VOTRIENT CPR.PELLIC. 400 mg 1*60 CPR.(FL.) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | n/a |
Luxembourg | (L01EX09) nintedanib (adm: O) | Ofev CAPS.MOL. 100 mg 60*1 caps.ss blist. | n/a | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis;Lung Diseases, Interstitial;Pulmonary Fibrosis;Scleroderma, Systemic | n/a |
Luxembourg | (L01EX09) nintedanib (adm: O) | Ofev CAPS.MOL. 150 mg 60*1 caps.ss blist. | n/a | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis;Lung Diseases, Interstitial;Pulmonary Fibrosis;Scleroderma, Systemic | n/a |
Luxembourg | (L01XK04) talazoparib | Talzenna GELUL. 0,25 mg 1*30 gélules (fl.PEHD) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01XK04) talazoparib | Talzenna GELUL. 1 mg 1*30 gélules (fl.PEHD) | n/a | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | n/a |
Luxembourg | (L01XX41) eribulin | Eribulin EG SOL.INJ. 0,44 mg / 1 mL 1*1 flacon 2 mL | n/a | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L02AE04) triptorelin | Decapeptyl Sustained Release PSV.SP.INJ. 3,75 mg 1*1 fl.pdre+ 1 amp.solv. + 1*1 ser.+ 2 aiguilles | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L02AE04) triptorelin | Decapeptyl Sustained Release PSV.SP.INJ. 11,25 mg 1*1 fl.pdre +1 amp.solv. + 1*1 ser.+ 2 aiguilles | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L02AE04) triptorelin | Decapeptyl Sustained Release PSV.SP.INJ. 22,5 mg 1*1 fl.pdre +1 amp.solv. + 1*1 ser.+ 2 aiguilles | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L03AA10) lenograstim (adm: P) | GRANOCYTE-34 PSV.SOL.I/P 33,6 MIOUI / 1 mL 1*5 FL. + 1*5 SER.PREREMPL. 1 ML | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | n/a |
Luxembourg | (L04AB04) adalimumab (adm: P) | Hulio SOL.INJ. 40 mg 1*2 ser.préremplies + 1*2 tampons d’alcool | n/a | Retail price with vat |
$0-0 |
$0-0 |
Hidradenitis Suppurativa;Psoriasis;Uveitis;Arthritis, Rheumatoid;Spondylitis, Ankylosing;Crohn Disease;Colitis, Ulcerative;Arthritis, Psoriatic | n/a |